Qualisus raises R$320m for Brazil modernisation
This article was originally published in Clinica
Brazil's Qualisus healthcare development programme received investments totalling R$320m (US$151m) in 2005, of which a significant share went to increasing and modernising infrastructural equipment. The number of projects undertaken more than trebled, from 30 to 92.
You may also be interested in...
Medical products that do not fully comply with Canadian requirements but are manufactured according to comparable standards are being allowed into the country to deal with COVID-19-related shortages.
A randomized COVID-19 study spanning the whole of the UK could help to bolster the UK’s reputation as a location for future clinical trials. It is also being seen partly as the result of the UK regulator's "decisive action" in fast-tracking trials for potential COVID-19 therapies.